Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Maclay, R. Rabinovich, D. McAllister, S. Hartland, M. Mathers, S. Maxwell, R. Weller, N. Mills, W. MacNee (Edinburgh, United Kingdom). LSC 2010 Abstract: Systemic elastin degradation in COPD. Eur Respir J 2010; 36: Suppl. 54, 2205

Member's Comments

No comment yet.

Related content which might interest you: LSC 2011 Abstract: Role of mast cells and chymase in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 LSC 2010 Abstract: Overexpression of Ang-(1-7)-fusion protein in the lungs prevents pulmonary fibrosis and accompanying pulmonary hypertension Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 LSC 2010 Abstract: Dynamics of inflammation and lung functioning in murine ozone model of COPD Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 LSC 2010 Abstract: Potential of ACE2 as a therapeutic target for pulmonary hypertension Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 LSC 2010 Abstract: Synthetic dsRNA exacerbates pulmonary inflammation in acute and sub-chronic in vivo models of COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 LSC 2013 abstract - Bioavailability of VEGF in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone Source: International Congress 2014 – ILDs 1 Year: 2014 LSC 2014 abstract - Influenza infection may cause exacerbation of lung fibrosis through collagen deposition Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014 Malanoyl dialdehyde (MDA) and hs-CRP: How are they linked to COPD? Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Vascular remodelling in COPD Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms Year: 2007 Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study Source: Eur Respir J 2010; 35: 540-548 Year: 2010 LSC 2011 Abstract: The role of lipoxin A4 in the chronic obstructive pulmonary disease Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 LSC 2011 Abstract: Inflammation and COPD: Protective effect of the recombinant anti-protease trappin-2 A62L, on lung epithelium Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Altered P2 receptor expression profile in sputum cells of patients with COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 LSC 2014 abstract - Evaluation of paraoxonase1 activity and its relationship to the severity of lung impairment in COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 The importance of pulmonary mineralogic analysis (PMA) in interstitial lung disease (ILD). A retrospective study of 226 samples from 2005 to 2011 Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013 Surface-bound TIMP-1 on PMNs promotes pericellular proteolysis: A new culprit in COPD? Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 LSC 2010 Abstract: Acute lung inflammation in response to carbon nanoparticle exposure is augmented in the absence of NF-kB Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014